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Summary. Twenty-nine isolates of avian infectious bronchitis virus (IBV) re-
covered from commercial chicken flocks in California between 1988 and 2001
and identified as California variants by serotype and direct automated cycle se-
quencing of the IBV spike glycoprotein S1 subunit, were further characterized
phylogenetically and by nucleotide sequence comparison.
California variants were grouped according to production type of chicken, by
comparison with public access sequence databases (NCBI GenBank and EMBL),
or based on phylogenetic analysis. Fisher’s Exact test was used to compare mu-
tations per year, purifying and positive selection, predictive antigenicity, and
a≥ 6 bp deletion between California variant groups.
A high number of mutations at the nucleotide level (p = 0.013) and a≥ 6 bp
deletion in the nucleotide sequence (p = 0.006)was significantly associated with
broiler-type chickens. However, 88% of significant comparisons at the amino acid
level such as purifying and positive selection were seen in layer-type chickens. A
pronounced predictive antigenicity in the HVR2 region was also associated with
layer-type chickens (p = 0.001). The study indicates that IBV in California is in
a phase of slow evolution with different evolutionary patterns being associated
with the production type of chicken.
Introduction
Avian infectious bronchitis virus (IBV) is an economically important disease
of chickens causing reduced performance, reduced egg quality and quantity,
increased susceptibility to infections, decreased profit at slaughter, and costly
vaccination programs (for review see [7]). IBV, a species in the genus Coronavirus,
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family Coronaviridae is distributed worldwide [11]. Because of the international
economic importance of one of the most important avian pathogens worldwide,
the virus is included among the Office International des Epizooties list B diseases.
Vaccines have generally been effective in controlling the clinical disease
associated with IBV infections, however escape mutants or variants continue to
cause clinical disease and production problems in vaccinated flocks [38], and
unique IBV variants may continue to circulate among poultry in geographically
isolated areas [36]. The continuing appearance of new IBV variants is associated
with the high rate of evolution, expressed as the accelerated rate at which viable
mutations accumulate in the genome, which is due to a lack of proofreading
enzymes seen in RNA viruses, nucleotide insertions, deletions, or point mutations
in S1 as the result of the viral polymerase [15, 16], as well as the high rate of
replication of the virus. Additionally, there is evidence that some IBV strains may
have arisen by genetic recombination [4, 30, 32], mutation [31] or a combination
of mutation and recombination [21].
Mutations in the antigenically important spike glycoprotein S1 subunit have
been shown to lead to the emergence and proliferation of variant serotypes [36]
associated with new disease outbreaks. Within the S1 subunit gene most of the
antigenic epitopes are formed from a few amino acids encoded in 2 hypervariable
regions, HVR1 [aa 54 to 68] and HVR2 [aa 116 to 141]. Numbering is based on
the Mass41 S1 protein sequence (accession# M21883, GenBank [25]).
The focus of this retrospective study was the molecular epidemiology of
the spike glycoprotein S1 subunit in California variants [2, 14] of IBV. The
objective of the study was to compare the number of nucleotide mutations per
year, codons, and amino acid sequences, to evaluate which mutations led to
altered amino acids, and to predict antigenicity values in the S1 subunit among
representative isolates recovered from different production types of chickens,
between January 1988 and May 2001. Several statistical approaches were utilized
in the analysis; including the Jukes and Cantor method [22] to estimate the number
of nucleotide substitutions assuming equal frequencies of the nucleotides and
accounting for the fact that more than one substitution can happen at one site,
the Nei-Gojobory calculation to estimate the synonymous changes (nucleotide
changes not leading to aa changes) and the number of non-synonymous changes
(nucleotide changes leading to aa changes), a z-test for Darwinian selection
to identify sequences favoring changes in aa sequence, a z-test for purifying
selection to identify nucleotide changes not causing a change in the resulting
aa sequence, and the Poisson correction distance to compare sequences on the aa
level accounting for the fact that multiple substitutions can occur at one site.
Material and methods
Sampling
In a retrospective study, a convenience sampling of 125 avian infectious bronchitis virus
isolates obtained from diagnostic case submissions to the California Animal Health and Food
Safety Laboratory System in San Bernadino, Fresno, or Turlock, California were evaluated.
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Viral isolates were serotyped by monoclonal antisera directed against the classical serotypes
IBV-Conn, Mass41, and Ark99 [24], and by monospecific polyclonal antisera for the above
viruses plus the more recent California variant [2, 14]. Genetic sequences of the IBV S1
subunit of each isolate were additionally compared to IBV S1 sequences in GenBank and
EMBL databases. In addition to the above serotypes, isolates with nucleotide identity in
the S1 region to the “Arkansas-like,” Holland, Pennsylvania and Delaware serotypes were
identified. Isolates showing an S1 subunit sequence similarity of > 80% to the prototype
California variants identified in GenBank (group 1 = GB# AF027510 and GB# AF027511;
group 2 = GB# AF004738 and GB# AF0027508) were selected for further study. Twenty-
nine isolates obtained from clinically affected broiler or broiler-breeder flocks (n = 12) or
layer flocks (n = 17) between 1988 and 2001, were utilized in the cDNA sequencing and
phylogenetic analysis.
Virus isolation and propagation
Avian infectious bronchitis viruses were isolated by standard egg inoculation techniques [1],
and chorioallantoic membranes harvested 48–72 hr post inoculation at second passage were
examined for the presence of IBV by a fluorescent antibody test [1]. Allantoic fluid harvested
from second passage eggs described above was stored at−70 ◦C for further analysis or virus
propagation.
Rapid RNA extraction and RT-PCR amplification
A rapid RNA extraction protocol was developed for IBV in allantoic fluid. Two hundred
µl allantoic fluid was added to 1 ml Catrimox-14 surfactantTM (Qiagen, Valencia, CA) and
15µl of 1 mg/ml yeast t-RNA (Life Technologies), vortexed for 2 min, incubated at room
temperature for 20 min, and the nucleic acid/surfactant complex was centrifuged at 14,000 rpm
for 5 min. After the supernatant was discarded, pellets were carefully washed with 1 ml of
sterile water, followed by addition of 1 ml of LiCl (2 M), vortexed for 2 min, and centrifuged
for 5 min at 14,000 rpm. The pelleted RNA was washed with 1 ml of ice-cold 70% ethanol and
vacuum-dried for 10 min at room temperature. RNA pellets were dissolved in 15µl of sterile
distilled water, and kept at−20 ◦C until used. Reverse transcriptase-PCR was performed using
a degenerate primer set CK4 and CK2 as described previously [25] to obtain the forward and
the reverse strand sequence of the partial S1 spike glycoprotein (aa 43–236, based on the
S-1 protein sequence of the Mass 41 strain (GB# 21883)). Standard PCR was performed in
duplicate for each isolate using AmpliTaq Gold DNA PolymeraseTM (PE Applied Biosystems
Inc.) and 45 amplification cycles in a GeneAmp PCR System 9600 thermal cycler (PEApplied
Biostystems Inc. Foster City, CA). Final elongation was performed by incubating samples
at 70 ◦C for 15 min. To verify amplification of the approximately 600 bp sequence, 10µl of
each PCR product was electrophoresed on a 1.8% agarose gel and stained with ethidium
bromide.
Purification and direct cycle sequencing
RT-PCR amplification products were purified using a Microcon-PCR column (Millipore
Corp., Bedford, MA) according to the manufacturer’s recommendation. cDNA was quantified
by optical density at 260 nm and 12 ng/ul was used as the sequencing template. Direct
automated cycle sequencing was performed using anABI PrismTM Big Dye Terminator Cycle
Sequencing Ready Reaction kit (PE Applied Biosystems Inc.) on a 377 DNA sequencer, by
a commercial service (Davis Sequencing Service, Davis, CA).
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Sequence and phylogenetic analysis
Sequencing data were edited using commercial software (Chromas, version 1.45, for PC,
Conor McCarthy, Griffith University, Australia). A consensus sequence was obtained for
each isolate using data from duplicate runs including both sequencing directions. Sequences
internal to the primers, having less than 99% reproducibility were not analyzed. Mutants were
clustered into 2 groups. Group 1 contained all variants with> 80% sequence similarity to prior
GenBank entries CV-9437 (GB#AF027510) and CV-1686 (GB#AF027511), and included the
first IBV California variant isolated in this study (CA/2/88). Group 2 contained variants with
> 80% sequence similarity to the original IBV California variant submitted to GenBank, CA
85-633 (GB# AF004738) and 1013 (GB# AF027508), and included most of the more recent
IBV variants and an isolate also first identified in 1988 (prototype CA/1215/88). Computer
analyses of nucleic acid and amino acid sequences were performed using the MacDNASIS Pro
version 3.5 (Hitachi) and Sequencher 3.0 (Gene Codes Corp.) programs. Aligned sequences
were cropped to a length of 426 bp (starting at 135 bp; numbering is based on the Mass41 S1
protein sequence (GB# M21883) [25]) to insure a consistent fragment analyzed within the
genome segment sequenced. Two sequences (CA/96/01 and CA/627/01) were both included
in the analysis despite an identical 426 bp sequence, because they showed distinct differences
within the cropped portion of their sequences. Multiple sequence alignment was performed
using the computer program Clustal W version 1.7 [40]. Molecular evolutionary analyses were
conducted using computer program MEGATM version 2.1 [29]. All evolutionary calculations
were performed using the complete deletion option, due to sites involved in gaps that may
evolve differently in different sequences. The sequence of CA/1215/88 was used as the
prototype in this study because it was believed to be the first isolate identified as a California
variant [2, 14] of IBV within the sampling period and also not showing the ≥ 6 bp deletion.
Nucleotide mutations were calculated by dividing the number of nucleotide differences by
the number of years between the isolation of the prototype CA/1215/88 and the individual
variant noting that counted mutations/year is a non-linear relationship with time as some
mutation sites may undergo repeated substitutions and mutation rate would be underestimated.
The number of nucleotide substitutions was also estimated using the Jukes and Cantor
method, which corrects for multiple substitutions at the same site [−3/4ln(1−4/3p), where
p = proportion of sites with different nucleotides] [22]. The R-ratio of nucleotide substitution
was defined as the number of transitions (a substitution of a purine for another purine,
or a substitution of a pyrimidine for another pyrimidine) to the number of transversions
(substitutions between pyrimidines and purines).
To get an impression of the percentage of silent mutations (synonymous) compared to the
percentage of mutations leading to aa changes (non-synonymous) and therefore functional
or structural differences, evolutionary differences based on the number of synonymous or
non-synonymous sites were computed by comparing the prototype sequence with variant
sequences on a codon-by-codon basis using the modified Nei-Gojobori method [19]. After
counting the number of differences (Sd , Nd ), these counts were adjusted by the number
of potential synonymous/non-synonymous sites (p-distance; pS, pN), and p-distances then
were corrected by the Jukes Cantor method to account for multiple substitutions at the same
site (dS, dN). Positive Darwinian selection, defined as selection favoring non-synonymous
substitutions, or a change in the aa, was tested using a one tailed z-test for large sample
sizes [z= (dN − dS)/Sqrt(Var(dS)+Var(dN))] with a level of significance of 5% testing the
hypothesis of dN > dS (dN= number of non-synonymous substitutions per non-synonymous
sites, dS= number of synonymous substitutions per synonymous sites). Purifying selection,
defined as selection in favor of synonymous substitutions or mutations that do not result in a
different aa, was performed testing the hypothesis of dS > dN. At the amino acid (aa) level
the number of mutations per year was calculated by dividing the number of aa differences by
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the number of years between the isolation of the prototype CA/1215/88 and the individual
variant. For a more accurate impression of the aa sequence changes, evolutionary distances
were computed on a residue-by-residue level. To adjust for multiple substitutions at the
same site assuming equality of substitution rates and equal amino acid frequencies, the
Poisson correction distance [d = − ln(1− p), where d =number of amino acids per site,
and p = proportion of different amino acids between 2 sequences] was used.
A rooted phylogenetic tree was constructed using a non-poultry coronavirus (Feline
Infectious Peritonitis virus (FIPV) GenBank acc# X06170) to visualize relationship among
CA isolates using the neighbor-joining method [39] based on the aa sequence with the Poisson
correction distance. Bootstrap interior branch test was carried out on 1,000 replicate data sets
to assess the confidence limits of the branch pattern [9]. A bootstrap support value of ≥ 70%
was considered significant. A rooted tree assumes a direction that corresponds to evolutionary
time; the closer a node is to the root of the tree, the earlier it appeared.
For comparison an unrooted tree was constructed to show the relationship between the
CA variants themselves using the neighbor-joining method based on the aa sequence with the
Poisson correction distance (data not shown). In unrooted trees, adjacent sequences are not
assumed to be evolutionarily closely related.
Predictive antigenicity
Sequences were tested for predictive antigenicity (http://www.embl-heidelberg.de/JaMBW/
3/1/7/) to evaluate possible associations between virus mutations at specific sites and antigenic
alterations. The method of Hopp and Wood [18] was used to design plots of hydrophilicity
value versus sequence position. The point of highest local hydrophilicity is believed to be part
of or neighboring an antigenic determinant [18]. Predictive antigenicity was tested in 4 areas
of the sequence. A sequence containing at least 2 peaks displaying a hydrophilicity value of
0.5 [23] on the EMBL-measurement scale, or one hydrophilicity peak of 0.75 in the HVR1
area [14 aa] was considered to be positive for predictive antigenicity. Sequences showing
at least 2 peaks of hydrophilicity of 0.75 height, or one hydrophilicity peak of 0.75 plus 2
hydrophilicity peaks of 0.5, or 4 peaks of hydrophilicity of 0.5 in the HVR2 area [32 aa] were
also considered as being positive. One hydrophilicity peak of 0.5 within nine aa upstream of
HVR1 or ten aa upstream of HVR2 was counted positive for predictive antigenicity.
Glycosylation analysis
Sequences were tested for putative O- and N-glycosylation sites [13] to evaluate possible dif-
ferences among the sequences (http://www.cbs.dtu.dk/services/NetOGlyc/; http://www.cbs.
dtu.dk/services/NetNGlyc/).
Statistical analysis
Statistical analyses of proportions, other than the z-test performed with MEGATM 2.1, were
performed with SPSS (Standard Version) using a Fisher’s exact test. Results with a p-value
of ≤ 0.05 were considered significant.
Nucleotide sequence accession numbers
The nucleotide sequences reported here have been deposited with the public access
database GenBank. The accession numbers are shown in Table 1. A standard
nomenclature was adopted for submission of isolates to GenBank that included
a two-digit alphabetic identifying geographical origin of the isolate followed by
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Table 1. California variant GenBank accession numbers
Identification IBV variants GenBank accession Production No. of nt- % of aa-
number numbers type1 differences2 differences2
1 CA/1215/88 AF488301 L 0 0
2 CA/2/88 AF488294 B 65 29
3 CA/179/94 AF488285 B 67 29
4 CA/1601/94 AF488286 B 94 39
5 CA/4065/95 AF488284 B 68 28
6 CA/100/97 AF488282 B 68 28
7 CA/157/97 AF488287 B 106 42
8 CA/452/97 AF488283 B 67 28
9 CA/1489/97 AF488281 B 66 28
10 CA/5069/97 AF488288 B 107 47
11 CA/376/98 AF488277 L 44 26
12 CA/516A/98 AF488278 L 44 25
13 CA/561/99 AF488293 L 96 31
14 CA/588/99 AF488275 B 86 29
15 CA/3402/99 AF488296 L 39 23
16 CA/3760/00 AF488289 B 113 48
17 CA/3761/99 AF488290 B 61 30
18 CA/5442/99 AF488291 L 44 25
19 CA/37/00 AF488292 L 96 41
20 CA/354/00 AF488295 L 89 35
21 CA/1030/00 AF488297 L 118 49
22 CA/1031/00 AF488298 L 97 43
23 CA/1032/00 AF488299 L 63 28
24 CA/1033/00 AF488300 L 101 43
25 CA/96/01 AF469167 L 73 29
26 CA/291/01 AF488279 L 60 25
27 CA/389/01 AY038997 L 72 30
28 CA/541/01 AF488280 L 77 29
29 CA/627/01 AF488276 L 77 29
1Production type of the chicken: L= layer, B= broiler
2Number of differences compared to the prototype CA/1215/88
a numeric or alphanumeric unique laboratory identifier, and a two digit numeric
identifying the year of isolation, taking the form CA/1215/88.
Results
Nucleotide sequence comparison
Twenty-nine sequences of 426 bp each including the 2 HVRs in the S1 subunit
gene of IBV were aligned and analyzed. The GC content in the sequences ranged
from 35.5% to 39.5% with a mean of 37.3%. Because AT richness in the 3rd
codon position might increase the apparent rate of aa changes [20], the relative
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frequency of the four nucleotides in the third codon position was counted and
resulted in a mean AT richness of 76.8% (range 65.9% to 81.8%). The average
number of mutations in the 426 bp nucleotide sequence per year ranged from
3.55 (CA/3402/99: 39/11 [nt differences compared with the prototype]/[number
of years between isolation of prototype and variant]) to 15.67 with a mean of
7.92. The number of mutations/year for a single isolate, CA/2/88, could not be
calculated, because the virus was recovered in the same year as the prototype.
Sixty-five nucleotide differences were counted between these two sequences. The
average number of nucleotide mutations for isolates obtained from layer birds was
6.23 (CA/1215/88 not included), whereas the mean mutation number in broiler
and broiler-breeder birds was calculated as 9.65 per year (CA/2/88 not included).
The isolates within GenBank group 1 showed an average mutation number of
8.38 per year, whereas those in group 2 showed 6.52 mutations per year. The
Jukes Cantor evolutionary distance ranged between the individual variants and
prototype CA/1215/88 from 0.109 to 0.395 and a mean value of 0.238 (Fig. 1), with
the larger distance values between two sequences corresponding to less similarity.
Figure 1 displays the evolutionary distances among all variants studied. The R-
ratio (transition/transversion) ranged from 0.47 to 1.0 between the prototype
and the variants with a mean ratio of 0.738 with a low R-ratio indicating an
overall slow evolutionary rate. Sequence alignment of the variants revealed a 6,
or greater than or equal to 9 basepair deletion starting at position 174. At the
corresponding location, AATACA, AATGCA, AATTCA, AATGCG, or AATCCA
were seen in sequences not showing the deletion, except in CA/3760/99, which
showed CGGGCT (Table 2). A second, 3 bp deletion site was detected at position
234 in CA/1601/94, CA/157/97, CA/5069/97, CA/1030/00, CA/1031/00, and
CA/1033/00. All other sequences had the nucleotides GCA in the described
location, except CA/3760/99 with TTA, and CA/37/00 with GGC.
Positive selection
To detect a positive Darwinian selection at the amino acid level, it is necessary
to show that the number of aa changes is significantly greater than that of silent
mutations for the whole segment studied. Nine variants CA/376/98, CA/516A/98,
CA/1601/94, CA/157/97, CA/5096/97, CA/37/00, CA/3402/99, CA/1030/00, and
CA/10/31/00 were found to have excess of non-synonymous changes, leading to
replacement of aa. The large sample z-test (dN > dS) was significant for
CA/1030/00 (p = 0.039), which was the only IBV variant revealing a predisposi-
tion to altered aa composition compared with the prototype CA/1215/88. Layers
and broilers, if considered separately, showed the same evolutionary distance
(mean value for aa changes compared to silent mutations) of 0.047. GenBank
group 1 variants showed a mean value of 0.079 (indicating excess of mutations
leading to aa changes), whereas GenBank group 2 variants displayed a mean
distance value of −0.009 (indicating excess of silent mutations).
The z-test calculation testing the positive selection hypothesis in the HVR1
region was significant only for a single isolate, CA/354/00 (p < 0.035). The
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Table 2. IBV variants not showing a six or ≥ 9 bp deletion in their nucleotide sequence alignment
with their corresponding amino acids. The GenBank group assignment of the IBV variants are
displayed in column 2
IBV variants CA group nt nt nt aa 58 aa 59 aa 60
assignment 174–176 177–179 180–182
CA/1215/88 group 2 AAT GCA GGT asparagine alanine glycine
CA/376/98 group 2 AAT GCA GGT asparagine alanine glycine
CA/516A/98 group 2 AAT GCA GGT asparagine alanine glycine
CA/561/99 group 1 deletion deletion AGG deletion deletion arginine
CA/588/99 group 1 deletion deletion AGG deletion deletion arginine
CA/3402/99 group 2 AAT GCA GGT asparagine alanine glycine
CA/3760/99 group 2 CGG GCT CAG arginine alanine glutamine
CA/3761/99 group 2 AAT GCG GGC asparagine alanine glycine
CA/5442/99 group 2 AAT GCA GGT asparagine alanine glycine
CA/354/00 group 1 AAT GCA GGT asparagine alanine glycine
CA/37/00 group 1 AAT GCA GGT asparagine alanine glycine
CA/96/01 group 1 AAT ACA GGT asparagine threonine glycine
CA/291/01 group 1 AAT GCA GGT asparagine alanine glycine
CA/389/01 group 1 AAT TCA GGT asparagine serine glycine
CA/541/01 group 1 AAT GCA GGT asparagine alanine glycine
CA/627/01 group 1 AAT ACA GGT asparagine threonine glycine
z-test calculations testing the predisposition to altered aa in only the HVR2 region
(located between aa 116 and 141) were significant for 4 variants (p < 0.006).
Testing the same hypothesis for HVR1 and HVR2 together without omitting the
genetically stable portion of the S1 sequence between the two regions, demon-
strated significant results in 4 variants (p < 0.003). There was a statistically
significant association between the predisposition to altered aa in HVR1 and
HVR2 combined (HVR1+ 2) and the grouping according to GenBank (p =
0.021). Variants in GenBank group 2 were more likely to show predisposition
to altered aa in HVR1+ 2, however there was no statistical association between
predisposition to altered aa found in HVR1+ 2 and the production type of the
chicken (p = 0.1).
Purifying selection
Testing for a purifying selection, where number of silent mutations exceeds num-
ber of mutations leading to aa changes, no significant results were seen at the 5%
level within only HVR1, only HVR2, or HVR1+HVR2. Calculation of purifying

Fig. 1. S1 amino acid sequence alignment pair distances (Poisson correction) are displayed
in the lower-left matrix, and S1 nucleic acid sequence alignment pair distances (Jukes-Cantor)
are printed in the upper-right matrix. Larger distances between two sequences represent less
similarity. Code numbers are displayed in Table 1
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selection of the entire 426 bp segment, identified two IBV variants (CA/588/99 and
CA/561/99) at the 5% level of significance. There was no statistical association
between a variants showing a predominance of silent mutations and the production
type of the chicken (p = 0.665).
Amino acid sequence comparison
Amino acid sequences in the IBV variants had an average content of 59.05% non-
polar residues and 40.95% polar residues, indicative of membrane bound proteins
(proteins immersed in a non-polar environment requiring a hydrophobic exterior).
Of all amino acids, glutamic acid was detected least frequently, with a mean of
0.99% (range 0% to 2.14%). Valine was detected most commonly with a mean
of 9.33% (range 7.19% to 11.35%). The number of differences in the amino acid
composition compared with the study prototype CA/1215/88, ranged from 23
(Poisson corrected distance: 0.207) to 49 (Poisson corrected distance: 0.508) with
a mean value of 32.7 (Poisson corrected distance: 0.313). The average number
of aa differences per year between the prototype and each variant ranged from
1.92 (CA/291/01) to 6.50 (CA/1601/94) with a mean value of 3.24 aa changes
per year, and was not related to the time between isolation of the prototype and
isolation of the variant. Evolutionary distances between the prototype and the
variants as well as among the variants themselves are displayed in Fig. 1, where a
larger distance between two sequences indicates less similarity. IBV isolates from
broilers averaged 34 amino acid differences from the prototype, whereas IBV
mutants from layers averaged 32 amino acid differences from the prototype. The
average number of amino acid differences between the prototype and phylogenetic
group was 32 (Poisson corrected distance: 0.298) for GenBank group 1 and 35
(Poisson corrected distance: 0.337) for GenBank group 2.
Though not part of the consensus sequence analyzed, it was noted that part
of the ‘HGGAY’ aa motif within the reportedly conserved CK4 primer region
described by Keeler et al. [25] was only observed in 18 of 29 isolates studied
(Fig. 2). All replacements led to a larger total size of the amino acid in the motif,
except the replacement combination found in CA/1215/88, suggesting a possible
change in the three dimensional structure of the protein at this site. Two additional
deletions were detected during the nucleotide alignment: one deletion (≥ 2aa)
starting at aa position 78 and one deletion at aa position 121 (Fig. 2).
Phylogenetic tree
Based on the amino acid sequences with elimination of indels, a phylogenetic tree
rooted to the coronavirus FIPV was established (Fig. 3). To show the relationship
among the CA variants themselves, an unrooted tree based on the aa sequences
was constructed and resulted in a bifurcating tree displaying two main branches
(subgroup A and B), each of them further dividing. Subgroup A consists of all
16 variants having small evolutionary distances from the prototype as shown
in the rooted tree. Subgroup B includes 13 variants with larger evolutionary
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Fig. 3. Rooted phylogenetic tree describing the ancestor-descendant relationships between
aa sequences of IBV variants isolated between 1988 and 2001 in California and the distant
related FIP virus. The closer a node is to the root of the tree, the more similar to the prototype.
Horizontal and vertical branch lengths are not significant. Interior branch values (shown when
≥ 70%) represent the percent occurrence of that clade per 1.000 bootstrap replicates
Genetic diversity of California IBV variants 129
distances (Fig. 3). Subgroup A with the shorter evolutionary distances contains
predominantly variants isolated from layer chickens (13 layer versus 3 broiler
[CA/3760/99, CA/3761/99, CA/588/99]), whereas subgroup B displays mostly
isolates from broiler chickens (9 broiler versus 4 layer [CA/1030/00, CA/1031/00,
CA/1032/00, CA/1033/00]). IBV variants with ≥ 9 bp nucleotide deletion were
located in subgroup B and were found with the 2 isolates having a 6 bp nucleotide
deletion in the upper main branch of the phylogenetic tree. Most of the IBV variants
(15/16) included in subgroup A were isolated after 1997, except CA/1215/88 (the
prototype for this study), which was isolated in 1988 from layer birds. Ten of
13 IBV variants displayed in subgroup B were isolated between 1995–1997 and
1999/2000. There was no statistical association between the grouping according to
GenBank and the location in either subgroup of the phylogenetic tree (p = 0.244),
however a significant association between the production type and the location
of the variants in the subgroups (0.008) was seen. Significant associations were
also found between the location of the variants in the “phylogenetic tree and a
high number of nucleotide mutations/year (p = 0.005), with positive antigenicity
values in HVR-2 (p ≤ 0.001), as well as with the occurrence of a deletion in
HVR-1 (p ≤ 0.001).
Predictive antigenicity
Predictive antigenicity was evaluated within four areas of each sequence within
the HVR and at least 9 aa upstream in conserved regions of the genome (Fig. 2)
and reported as either positive or negative for antigenicity as measured by values
expressing the relative hydrophilicity of each aa averaged over the length of
the polypeptide chain. Sixty-five percent of the evaluated layer-type sequences
and 71% of the broiler sequences, 68% of the total sequences, showed positive
predictive antigenicity within 9 amino acids upstream of HVR1. Only 10% of the
sequences displayed predictive antigenicity within the HVR1. Six percent within
the layer-type sequences, and 17% within the broiler sequences were positive
for predictive antigenicity in HVR1. Twelve percent of the evaluated layer-type
sequences and 50% of the broiler sequences, 28% of the total sequences, showed
positive predictive antigenicity within 10 amino acids upstream of HVR2. In
HVR2 itself 59% of the layer type sequences had a positive predictive anti-
genicity value, whereas no positive sequences were found among the broiler
sequences.
Glycosylation analysis
O- and N-glycosylation sites are shown in Fig. 2. All sequences show a N-
glycosylation site at aa position 103 and 145 within the conserved part of the
sequence. Sixty-nine % (20/29) of the sequences display a N-glycosylation site
at aa position 51 within the HVR-1, and 62% of the sequences (18/29) show a
putative N-glycosylation site at aa position 135 within the HVR-2 region.
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Statistical evaluation
Fisher’s Exact test showed an association between the production type of chicken
and the number of nucleotide mutations/year at a chosen cut off point of 7
mutations per year (p = 0.013). IBV variants isolated from broilers demonstrated
a higher number of mutations/year on the nucleotide level compared with IBV
variants isolated from layers. There was no association between a high number
of mutations/year and the GenBank group of the variants (p = 0.198). IBV
variants isolated from broilers were also more likely to have the ≥ 6 bp deletion
in their nucleotide sequence compared with IBV variants isolated from layers
(p = 0.006). There was no association between the appearance of the deletion
and the GenBank group of the variant (p = 0.099). An association was identified
between the production type of the chicken and the GenBank grouping of the
IBV variant (p = 0.028). IBV variants isolated from broilers were more likely
to belong in the original or group 1 California variant group. The production
type of chicken was also associated with predictive antigenicity in ten amino
acids upstream of HVR2 (p = 0.033), and in HVR2 (p = 0.001). Predictive
antigenicity was more likely to be found in variants isolated from layer-type birds,
and those located in the subgroup A (closer to the prototype) of the phylogenetic
tree (p < 0.001). Predictive antigenicity in HVR2 was associated with a high
number of mutations/year on the nucleic acid level (p = 0.008), showing that
sequences with more than 7 mutations per year were more likely to have a positive
predictive antigenicity value. A p-value of < 0.001 was also found testing the
association between the presence of the≥ 6 bp deletion and predictive antigenicity
in HVR-2. Variants showing predictive antigenicity in HVR2 did not display the
deletion. A positive predictive antigenicity in HVR2 was also associated with
being located in the Subgroup A (closer to the prototype) of the phylogenetic tree
(p < 0.001). A significant association between antigenicity and changing of aa
sequences in HVR-2 was not found (p = 0.105).
Discussion
The S1 gene of IBV has serotype specific and neutralization specific epitopes
[3, 27, 34, 37]. Antigenic variability and cross-protection between serotype and
virus are believed to be limited [33], a phenomenon that has stimulated much
research interest in the antigenic HVRs in S1 of IBV [5, 21, 33, 36, 37, 41].
This study documents different evolutionary patterns of IBV depending on the
production type of chicken (layer versus broiler).
The fact that 88% of all significant, directed evolutionary changes such as
the conservation of aa as measured by purifying selection, and positive selection
measured by a change of the aa, was found in variants isolated from layer-type
birds suggests that IBV variants isolated from layer chickens show a higher
potential and/or evolutionary need to respond to external pressures, whereas a
higher number of mutations/year on the nucleotide level without subsequent amino
acid changes were seen in IBV variants isolated from broilers. Mutations on
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the nucleotide level occur in IBV in poultry constantly, but the life expectancy
of the two different production types is probably responsible for the different
outcomes. In broilers, with an average life expectancy of only 6 weeks, there is not
sufficient pressure placed on the virus to avoid immune surveillance. Therefore the
mutations on the nucleotide level observed are most likely due to the high mutation
rate of RNA viruses in general [15, 16] combined with limited transmission
opportunity over the relatively short lifespan of the bird or flock. On the other hand,
layers could be subject during their more than one year life span [11] to several
IBV infections in addition to routinely administered IBV-vaccines, resulting in
selective immune pressures toward evolutionary change expressed in aa changes
and positive predictive antigenicity. Though the association between evolutionary
conservation of aa in the sequenced S1 gene fragment and the production type of
the chicken was not statistically significant in our analysis, the findings may be
different with a larger sample size.
The production type of chicken and the location of the IBV variants in the
phylogenetic tree subgroup were associated. Two IBV isolates recovered from
broilers (CA/3760/99, CA/3761/99), but located with layers in subgroup A of
the phylogenetic tree were recovered from black skin chickens produced for a
specialty market. The same isolates showed closer evolutionary distances to the
prototype in the rooted tree. These specialty birds are used as breeders and layers
as well as for meat production, and therefore do not represent typical genetics or
management practices seen in broilers or layers. The different genetic makeup,
the multipurpose production type, and the different management type, including
extended life span of this breed might explain why variants isolated from these
birds were more closely linked to the IBV variants associated with layer-type
birds. Interestingly those two variants form a possible independent branch in the
unrooted tree, if tree reconstruction is based only on aa sequences in the HVRs
(data not shown). Both variants were isolated in the same year (1999), and within
the same zip-code area (data not shown), and a geographical influence such as
airborne transmission [8] cannot be excluded in this case. Other possible sources
of virus might include outside introductions through the use of feed mills or other
shared management practices.
Some IBV variants isolated from layer type chickens were phylogenetically
grouped (Subgroup B) with the variants isolated predominantly from broilers
and show the 9 base-pair deletion. Despite the statistical association between
the broilers and the deletion, variants containing the deletion were occasionally
recovered from layer-flocks, suggesting that the deletion itself is not responsible
for the association with chicken production type. Three of these variants were
isolated from the same zip-code area and the zip-code for the fourth could not
be retrieved. The findings are consistent with Moore et al. [36] who showed that
IBV variants with unique HVRs circulate in geographically isolated areas in the
United States.
A ≥ 6 bp deletion was observed within the HVR1 in all variants located in
Subgroup B of the phylogenetic tree, placing this group evolutionarily further
from the prototype. The observed deletion was consistent, so presumed not to be a
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random sequencing error or phenomenon created during laboratory passage of the
original IBV isolate, leading to the conclusion that IBV variants display mutations
without frame shifts within the HVR1. Interestingly, CA/561/99 and CA/588/99
are the only variants with a 6 bp deletion that were grouped into Subgroup A in
the phylogenetic tree. The different phylogenetic grouping of the 6 bp and the
≥ 9 bp deletion suggest the 2 deletions are not evolutionarily associated despite
similar location in the HVR1. The two deletion variants appear to be circulating in
different pools of chickens, and just coincidentally, or possibly for an evolutionary
advantage, have deletions located at the same position.
Subgrouping of IBV variants using the phylogenetic tree is not necessarily
consistent with GenBank grouping. The difference between the two methods is
due to the small number of nucleotides per variant that the GenBank match was
based on. Wang et al. showed that phylogenetic grouping of only the S1 HVR
amino acid sequences provides similar results to those obtained from sequencing
the entire S1 genome [41]. However, trends toward mutations or conservation
of specific aa patterns found in HVRs cannot be generalized for the entire S1
gene based on our study, showing that even though HVRs are thought to function
as the center of diversity, mutations in more stable parts of the sequence were
also detected. Additionally, the ratio of aa changes to silent mutations and the
significance of the hypothesis testing for aa changes was different for HVRs
compared to the larger S1 sequence, suggesting that HVR2 is predisposed to
alterations in the aa pattern compared to HVR1. We can speculate that the neu-
tralizing epitopes associated with HVR2 might be more important for making
the first virus contact with the epithelial cells in affected poultry. Predictive
antigenicity in HVR2, found only in variants isolated from layer type chickens,
was also significantly linked to an overall number of less than 7 mutations per
year, not having a ≥ 6 bp deletion, and being located within the Subgroup A of
the phylogenetic tree. These characteristics all distinguish sequences according
to the production type of bird. This result also seems to emphasize the selective
pressure on IBV isolates from layer-type chickens toward change. However, we
did not find any significant associations between predisposition to altered aa in
HVRs or in the entire sequenced area, and predictive antigenicity. We explain the
missing association with the possibility that some antigenic determinants might
not be correlated with hydrophilicity and would not be assessed with a predictive
antigenicity evaluation based on the principle of the greatest local hydrophilicity
[18]. The non-significant association between predisposition to altered aa and
predictive antigenicity, and especially the fact that CA/516A/98 does not show
a positive predictive antigenicity value despite a predisposition toward altered
aa in HVR2, might be examples of evolution without increasing hydrophilicity.
Further immunologic studies, including field trials are needed to confirm predicted
antigenicity, and to evaluate the impact of changes in HVR1 and HVR2 on the
three-dimensional structure of epitopes. Though the population of variants studied
was too small to statistically evaluate clinical disease association (data not shown),
there is an interesting trend toward increased severity of disease that deserves
further evaluation.
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GenBank variant group might be linked to an evolutionary pattern, as sug-
gested by results showing that variants closely related to CA 85-633 and 1013
may be constantly changing in the HVR-related epitopes, whereas variants closely
related to CV-9437 and CV-1686 are more likely to remain structurally constant.
An observed high mean nucleotide number of 8 mutations/year in concert with
the fact that only one variant tested positive for an altered aa pattern seems to
be unusual for a genomic sequence including two HVRs. It would be expected,
that a high number of nucleotide mutations per year does conform to higher
predisposition to altered aa in the group 1 variants, which are predominantly from
broiler type birds. Additionally, the AT richness in the 3rd codon position can
increase the apparent rate of non-synonymous substitution [20] and would favor a
predisposition to altered aa, meaning that among the IBV isolates evaluated, fewer
than five mutants might show true predisposition to altered aa. In the population
studied, a period of slow evolution despite a rapid replication of the virus and a high
mutation frequency was observed. Eigen et al. [10] explained this phenomenon
by demonstrating that in constant environments selection for fit of the master
sequence occurs. Such periods of relative stasis do not imply that the viruses are
incapable of rapid evolution under different circumstances [17]. High numbers
of nucleotide mutations per year that do not result in altered aa, as seen in IBV
variants from broilers, suggest a neutral polymorphism [26]. Cavanagh et al.,
reported a low mutation rate (10−4/year) at the nucleotide level in British and
French IBV isolates collected from both production types [6], and associated the
low mutation rate with a small immune pressure on the S1 protein to change. Our
results demonstrate different findings depending on the production type of the
chicken, with layer birds having evidence of more immune pressure to change.
A conserved amino acid sequence (‘HGGAY’) on which the widely used
CK4 primer was developed [25] was not observed in all IBV variants evalu-
ated in this study, emphasizing the importance of the three wobble bases in the
highly degenerate CK4 primer. Though unexpected, our results are consistent
with unpublished observations (J. Gelb, personal communication, 2002). Most
of the observed changes in the motif are radical changes [19], increasing the
polarity and/or the hydrophobicity of the sequence. Those changes might suggest
an adaptation allowing improved, membrane fusion and attachment functions as
well as increased ability to avoid neutralization [35]. The observation also allows
the speculation that the CK4 primer does not detect all IBV variants.
Possible sequencing errors cannot be excluded despite the clear statistical
data concerning associations between production type, mutant type, and number
of mutations/year. In fact, 2 sequences eliminated from this study that were very
similar on the nucleotide level appeared to have had frame shift mutations, because
no plausible protein-reading frame could be designated. It is also possible that
other sequences might have multiple frame shift mutations that would not result
in a stop codon, sequence mutations that occurred during passage of the virus in
the laboratory [15], or due to errors in the techniques [28]. An imperfection in
the current study that should be corrected in future work is the addition of a
housekeeping gene as an assay control.Additionally an unknown variable resulting
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from the choice of convenience sampling is the unknown time period flocks or the
representative sentinel chickens were infected with the particular variants prior to
isolation.
The results of the study provide data suggesting that different management
environments play a role in the evolution of IBV, and further epidemiologic
tracking of variants is warranted.
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